slas Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Can Pharma R&D Satisfy the New Healthcare Market?

A more attentive FDA and a more demanding healthcare market are forcing pharmaceutical companies to change the way they have done business for decades. Research and development is perhaps the most impacted by both of these market dynamics. After all, without new products...

source: By Mike Wokasch
Search past issues
Search products and services

Glioblastoma multiforme is the most aggressive form of brain cancer with marginal life expectancy. Based on the assumption that GBM cells gain functions not necessarily involved in the cancerous process, patient-derived...

source: Cell

Drawing upon a wealth of experience of working with a wide range of 3-D cell culture procedures and formats, AMSBIO has produced an extensive 48-page handbook for research scientists looking to culture cells in more physiologically relevant environments. Over the past two...

source: AMSBIO

A free, downloadable whitepaper from Oxford Gene Technology provides researchers the opportunity to explore the latest strategies in the genomic characterization of complex disorders and to discover how, when used alongside sequencing, microarrays play a vital role in delivering...

source: Oxford Gene Technology

If you have not yet joined the discussion on the SLAS LinkedIn forum, you are missing out. Recent posts...

source: SLAS

SLAS2015 keynote speaker and NIH Director Francis Collins blogs about...

source: SLAS

Congratulations to Code Orange 3476, a high school FIRST team from Irvine, CA, mentored by SLAS member...

source: SLAS


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063